Literature DB >> 29084832

Cord Blood Banking for Potential Future Transplantation.

William T Shearer, Bertram H Lubin, Mitchell S Cairo, Luigi D Notarangelo.   

Abstract

This policy statement is intended to provide information to guide pediatricians, obstetricians, and other medical specialists and health care providers in responding to parents' questions about cord blood donation and banking as well as the types (public versus private) and quality of cord blood banks. Cord blood is an excellent source of stem cells for hematopoietic stem cell transplantation in children with some fatal diseases. Cord blood transplantation offers another method of definitive therapy for infants, children, and adults with certain hematologic malignancies, hemoglobinopathies, severe forms of T-lymphocyte and other immunodeficiencies, and metabolic diseases. The development of universal screening for severe immunodeficiency assay in a growing number of states is likely to increase the number of cord blood transplants. Both public and private cord blood banks worldwide hold hundreds of thousands of cord blood units designated for the treatment of fatal or debilitating illnesses. The procurement, characterization, and cryopreservation of cord blood is free for families who choose public banking. However, the family cost for private banking is significant and not covered by insurance, and the unit may never be used. Quality-assessment reviews by several national and international accrediting bodies show private cord blood banks to be underused for treatment, less regulated for quality control, and more expensive for the family than public cord blood banks. There is an unquestionable need to study the use of cord blood banking to make new and important alternative means of reconstituting the hematopoietic blood system in patients with malignancies and blood disorders and possibly regenerating tissue systems in the future. Recommendations regarding appropriate ethical and operational standards (including informed consent policies, financial disclosures, and conflict-of-interest policies) are provided for physicians, institutions, and organizations that operate or have a relationship with cord blood banking programs. The information on all aspects of cord blood banking gathered in this policy statement will facilitate parental choice for public or private cord blood banking.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 29084832      PMCID: PMC6091883          DOI: 10.1542/peds.2017-2695

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  34 in total

Review 1.  Umbilical cord blood collection, storage and use: ethical issues.

Authors:  Carlo Petrini
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

2.  Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

Authors:  Juliana F Fernandes; Vanderson Rocha; Myriam Labopin; Benedicte Neven; Despina Moshous; Andrew R Gennery; Wilhelm Friedrich; Fulvio Porta; Cristina Diaz de Heredia; Donna Wall; Yves Bertrand; Paul Veys; Mary Slatter; Ansgar Schulz; Ka Wah Chan; Michael Grimley; Mouhab Ayas; Tayfun Gungor; Wolfram Ebell; Carmem Bonfim; Krzysztof Kalwak; Pierre Taupin; Stéphane Blanche; H Bobby Gaspar; Paul Landais; Alain Fischer; Eliane Gluckman; Marina Cavazzana-Calvo
Journal:  Blood       Date:  2012-02-03       Impact factor: 22.113

Review 3.  Ethical issues in umbilical cord blood banking: a comparative analysis of documents from national and international institutions.

Authors:  Carlo Petrini
Journal:  Transfusion       Date:  2012-07-31       Impact factor: 3.157

4.  Are hybrid umbilical cord blood banks really the best of both worlds?

Authors:  Gregory M T Guilcher; Conrad V Fernandez; Steven Joffe
Journal:  J Med Ethics       Date:  2014-05-13       Impact factor: 2.903

Review 5.  Haematopoietic stem cell transplantation for SCID patients: where do we stand?

Authors:  Marina Cavazzana-Calvo; Isabelle André-Schmutz; Alain Fischer
Journal:  Br J Haematol       Date:  2012-11-20       Impact factor: 6.998

6.  A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.

Authors:  Mark B Geyer; Judith S Jacobson; Jason Freedman; Diane George; Virginia Moore; Carmella van de Ven; Prakash Satwani; Monica Bhatia; James H Garvin; Mary Brigid Bradley; Lauren Harrison; Erin Morris; Phyllis Della-Latta; Joseph Schwartz; Lee A Baxter-Lowe; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2011-08-16       Impact factor: 6.998

Review 7.  Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.

Authors:  Hal E Broxmeyer
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

8.  Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.

Authors:  Mitchell E Horwitz; Nelson J Chao; David A Rizzieri; Gwynn D Long; Keith M Sullivan; Cristina Gasparetto; John P Chute; Ashley Morris; Carolyn McDonald; Barbara Waters-Pick; Patrick Stiff; Steven Wease; Amnon Peled; David Snyder; Einat Galamidi Cohen; Hadas Shoham; Efrat Landau; Etty Friend; Iddo Peleg; Dorit Aschengrau; Dima Yackoubov; Joanne Kurtzberg; Tony Peled
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

9.  Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation.

Authors:  T Yasuda; T Ueno; K Fukumura; A Yamato; M Ando; H Yamaguchi; M Soda; M Kawazu; E Sai; Y Yamashita; M Murata; H Kiyoi; T Naoe; H Mano
Journal:  Leukemia       Date:  2013-09-26       Impact factor: 12.883

10.  A History of Cord Blood Banking and Transplantation.

Authors:  Joanne Kurtzberg
Journal:  Stem Cells Transl Med       Date:  2017-05       Impact factor: 6.940

View more
  13 in total

Review 1.  Rejuvenating the human gut microbiome.

Authors:  Shanlin Ke; Scott T Weiss; Yang-Yu Liu
Journal:  Trends Mol Med       Date:  2022-06-30       Impact factor: 15.272

2.  Allele and Haplotype Frequencies of HLA-A, -B, -C, and -DRB1 Genes in 3,750 Cord Blood Units From a Kinh Vietnamese Population.

Authors:  Tran Ngoc Que; Nguyen Ba Khanh; Bach Quoc Khanh; Chu Van Son; Nguyen Thi Van Anh; Tran Thi Thuy Anh; Pham Dinh Tung; Nguyen Dinh Thang
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

3.  GFc7 as a Smart Growth Nanofactor for ex vivo Expansion and Cryoprotection of Humans' Hematopoietic Stem Cells.

Authors:  Amir Atashi; Mohammad Hassan Nazaran; Maryam Hafizi; Somayeh Kalanaky; Saideh Fakharzadeh; Ehsan Janzamin; Tarlan Arjmandi
Journal:  Int J Nanomedicine       Date:  2020-08-21

4.  How Knowledge about Stem Cells Influences Attitudes towards Breastfeeding: Case Study of Polish Women.

Authors:  Malgorzata Witkowska-Zimny; Dorota Majczyna
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

5.  Substrate stiffness directs the phenotype and polarization state of cord blood derived macrophages.

Authors:  Rebecca A Scott; Kristi L Kiick; Robert E Akins
Journal:  Acta Biomater       Date:  2020-12-26       Impact factor: 8.947

6.  The law and problematic marketing by private umbilical cord blood banks.

Authors:  Blake Murdoch; Alessandro R Marcon; Timothy Caulfield
Journal:  BMC Med Ethics       Date:  2020-07-01       Impact factor: 2.652

7.  Identifying Barriers to Umbilical Cord Blood Banking in Jordan: A Cross-Sectional Survey of Obstetricians.

Authors:  Fayez Abdulrazeq; Monica M Matsumoto; Reem Abduljabbar; Amira Al-Hajj; Melad Alayash; Rahaf Ballourah; Sumayya Issak; Zubeida Issak
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

8.  Maternity health professionals' perspectives of cord clamp timing, cord blood banking and cord blood donation: a qualitative study.

Authors:  Lisa Peberdy; Jeanine Young; Debbie Massey; Lauren Kearney
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-16       Impact factor: 3.007

Review 9.  Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges.

Authors:  Mohamed M Kamal; Dina H Kassem
Journal:  Front Cell Dev Biol       Date:  2020-01-29

10.  Therapeutic efficacy of umbilical cord-derived stem cells for diabetes mellitus: a meta-analysis study.

Authors:  Dina H Kassem; Mohamed M Kamal
Journal:  Stem Cell Res Ther       Date:  2020-11-16       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.